Get started
Atossa Therapeutics, Inc.

Long | ATOS

173
ATOS

Possible Scenario: Long
Target Prices TP1:3$, TP2: 5$, TP3: 7$
Timeframe: October 2023
Evidence: Price Actions, Money Flow

shkspr
no pain, no gain
Unveiling illusions, revealing wealth
Also on:
ATOSChart PatternsTechnical IndicatorsTrend Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
ATOSChart PatternsTechnical IndicatorsTrend Analysis
shkspr
no pain, no gain
Unveiling illusions, revealing wealth
Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.